Full text is available at the source.
Ethylmethylhydroxypyridine Succinate Limits Inflammatory-Degenerative Changes in the Hypothalamus and Corrects Disturbances in the Circadian Rhythm of Corticosterone Secretion in Aged Rats
Ethylmethylhydroxypyridine Succinate Reduces Inflammation and Aging Damage in the Brain's Control Center and Restores Daily Corticosterone Rhythm in Old Rats
AI simplified
Abstract
A 14-day treatment with ethylmethylhydroxypyridine succinate at 100 mg/kg reduced inflammatory cytokines in the hypothalamus of aged rats.
- Chronic low-grade inflammation in the hypothalamus is linked to aging.
- The treatment decreased levels of inflammatory cytokines IL-1β and TNFα.
- Increased expression of anti-inflammatory cytokines TGF-β1 and IL-10 was observed.
- Upregulation of growth factors VEGF and BDNF was noted, indicating enhanced cellular support.
- Markers of mitochondrial and synaptic growth showed improved levels after treatment.
- Reduced circulating corticosterone levels were associated with the treatment effects.
AI simplified